MAA
TTPH

Managed Account Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Managed Account Advisors’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$897K Buy
946
+588
+164% +$481K ﹤0.01% 2141
2015
Q1 		$262K Buy
358
+339
+1,784% +$255K ﹤0.01% 2379
2014
Q4 		$15K Buy
+19
New +$10.2K ﹤0.01% 2595

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Managed Account Advisors's TTPH Position: Q2 2015 in Review

Managed Account Advisors increased its Tetraphase Pharmaceuticals, Inc. (TTPH) stake by 164% in Q2 2015, buying an estimated $481K and bringing the position to 946 shares worth $897K. The position accounts for ﹤0.01% of the portfolio, ranked #2141.

Managed Account Advisors first reported a position in TTPH in Q4 2014 and has held it in 3 quarters since. 139 funds tracked by Wall St. Rank hold TTPH as of Q2 2015.

  • Managed Account Advisors held 946 shares of Tetraphase Pharmaceuticals, Inc. worth $897K as of Q2 2015.
  • Managed Account Advisors bought 588 Tetraphase Pharmaceuticals, Inc. shares in Q2 2015, an estimated $481K.
  • Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2141 holding.
  • Managed Account Advisors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and has held it in 3 quarters since.
  • 139 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.